Nvidia and 2 S&P 500 Stocks Up in a Down Market
The S&P 500 (NYSEARCA:SPY) is down today by 2.29% and stands at 1,187. Here are three rare stocks in the green.
NVIDIA Corporation (NASDAQ:NVDA): SemiAccurate reports Nvidia’s graphics processors have been designed into next-gen Apple (NASDAQ:AAPL) MacBooks, likely starting with spring models featuring Intel’s (NASDAQ:INTC) Ivy Bridge chips. This is a major loss for AMD which has been Apple’s main PC graphics chip supplier. NVDA shares recently traded at $14.15, up $0.22, or 1.58%. Its market capitalization is $8.59 billion. They have traded in a 52-week range of $11.47 to $26.17. Volume today was 13,474,686 shares versus a 3-month average volume of 19,854,900 shares. The company’s trailing P/E is 13.71, while trailing earnings are $1.03 per share.
Investing Insights: Intel and 2 Stocks Driving the DJIA Lower.
E*TRADE Financial Corporation (NASDAQ:ETFC): Continues to get a boost after top hedge fund manager David Tepper opened new position of nearly 1.2 million shares. ETFC shares recently traded at $8.30, up $0.07, or 0.85%. They have traded in a 52-week range of $7.74 to $18.13. Volume today was 4,293,426 shares versus a 3-month average volume of 7,266,860 shares. The company’s trailing P/E is 16.27, while trailing earnings are $0.51 per share. About the company: E*TRADE Financial Corporation provides online brokerage and related products and services primarily to individual retail investors. The Company’s products and services include investor-focused banking, primarily sweep deposits and savings products, and asset gathering.
Edwards Lifesciences Corp. (NYSE:EW): EW shares recently traded at $64.49, up $1.47, or 2.33%. They have traded in a 52-week range of $61.63 to $91.82. Volume today was 1,032,828 shares versus a 3-month average volume of 1,227,950 shares. The company’s trailing P/E is 32.42, while trailing earnings are $1.99 per share. About the company: Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company’s products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.
Don’t Miss: Former AIG Chief Suing U.S. for $25 Billion.